Composite Lymphoma

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Composite Lymphoma trials may be worth asking about

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT07007052

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl…

The goal of this clinical trial is to study the efficacy of the tagraxofusp + venetoclax combination in treatment-naive blastic plasmacytoid dendritic cell neop…

France33 participantsStarted 2025-12-11Updated 2026-07-01

Treatment: Venetoclax, Tagraxofusp

All recent trials (4 shown)

Active — Not RecruitingPhase 1/2

NCT05025800

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

This phase I/II trial finds out the best dose, possible benefits and/or side effects of ALX148 in combination with rituximab and lenalidomide in treating patien…

United States47 participantsStarted 2021-10-13Updated 2026-03-20

Treatment: CD47 Antagonist ALX148, Lenalidomide

CompletedPhase 1

NCT02541565

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma…

This pilot phase I trial studies the side effects of pembrolizumab and combination chemotherapy in treating patients with previously untreated diffuse large B-c…

United States30 participantsStarted 2015-11-24

Composite Lymphoma

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl…

All recent trials (4 shown)

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma…

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Phase II Study Evaluating the Efficacy and Safety of the Combination of Tagraxofusp and Venetoclax in Treatment-naive Bl…

All recent trials (4 shown)

ALX148, Rituximab and Lenalidomide for the Treatment of Indolent and Aggressive B-cell Non-Hodgkin Lymphoma

Pembrolizumab and Combination Chemotherapy in Treating Patients With Previously Untreated Diffuse Large B-cell Lymphoma…

Italian Multicenter Retrospective Observational Study on Transformed Lymphomas